SILVERARC CAPITAL MANAGEMENT, LLC
Q3 2026 13F filing
Updated 10 days ago70 disclosed positions worth $854.4M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KODIAK SCIENCES INC | $71.1M | 750.2K | 8.32% | — |
| 2 | C CELCUITY INC | $63.9M | 803.2K | 7.47% | — |
| 3 | C COGENT BIOSCIENCES INC | $50.4M | 1.57M | 5.90% | — |
| 4 | U UROGEN PHARMA LTD | $46.7M | 1.15M | 5.46% | — |
| 5 | I IMMUNOME INC | $45M | 2.09M | 5.27% | — |
| 6 | M MONTE ROSA THERAPEUTICS INC | $37.1M | 3.11M | 4.35% | — |
| 7 | S SAGIMET BIOSCIENCES INC | $37M | 3.75M | 4.33% | — |
| 8 | A ASCENDIS PHARMA A/S | $34.7M | 152.2K | 4.06% | — |
| 9 | R RHYTHM PHARMACEUTICALS INC | $33.2M | 348.3K | 3.88% | — |
| 10 | B BIOGEN INC | $25.5M | 112.8K | 2.98% | — |
| 11 | I IMMUNOVANT INC | $21.1M | 624.1K | 2.47% | — |
| 12 | D DIANTHUS THERAPEUTICS INC | $20.8M | 236.6K | 2.44% | — |
| 13 | O ORUKA THERAPEUTICS INC | $20.6M | 247.9K | 2.42% | — |
| 14 | E ERASCA INC | $19.5M | 1.33M | 2.28% | — |
| 15 | A ABIVAX SA | $17.4M | 175.7K | 2.04% | — |
| 16 | C CELLDEX THERAPEUTICS INC NEW | $15.8M | 487.6K | 1.85% | — |
| 17 | O OVID THERAPEUTICS INC | $14.8M | 5.95M | 1.73% | — |
| 18 | S SPYRE THERAPEUTICS INC | $13.5M | 151.2K | 1.57% | — |
| 19 | D DEFINIUM THERAPEUTICS INC | $13.2M | 345.9K | 1.54% | — |
| 20 | ? N/A HELIX ACQUISITION CORP III | $12.8M | 1.21M | 1.50% | — |
| 21 | A ALKERMES PLC | $12.2M | 300.4K | 1.42% | — |
| 22 | ? N/A CELLDEX THERAPEUTICS INC NEW | $12M | 370.7K | 1.41% | — |
| 23 | B C4 THERAPEUTICS INC | $11.5M | 3.45M | 1.35% | — |
| 24 | A AVALYN PHARMACEUTICALS INC | $10.8M | 378.4K | 1.26% | — |
| 25 | ? N/A ORIC PHARMACEUTICALS INC | $9.5M | 702.4K | 1.11% | — |
| 26 | C CERUS CORP | $9.4M | 3.95M | 1.10% | — |
| 27 | A ALX ONCOLOGY HLDGS INC | $9.1M | 6.57M | 1.07% | — |
| 28 | Z ZENAS BIOPHARMA INC | $9M | 334.1K | 1.05% | — |
| 29 | C COMPASS PATHWAYS PLC | $8.9M | 717.4K | 1.04% | — |
| 30 | R RAINIER ACQUISITION CORP | $8.7M | 853.9K | 1.02% | — |
| 31 | C COMPUGEN LTD | $8.5M | 3.59M | 1.00% | — |
| 32 | S SAVARA INC | $7.8M | 1.52M | 0.92% | — |
| 33 | P VAXCYTE INC | $7.1M | 125.1K | 0.83% | — |
| 34 | ? N/A YARROW BIOSCIENCE INC | $6.8M | 301.9K | 0.80% | — |
| 35 | ? N/A IBIO INC | $6.3M | 5.36M | 0.74% | — |
| 36 | A ARCTURUS THERAPEUTICS HLDGS | $6.3M | 459.9K | 0.74% | — |
| 37 | ? N/A MONTE ROSA THERAPEUTICS INC | $6.3M | 525.0K | 0.73% | — |
| 38 | P PRAXIS PRECISION MEDICINES I | $5.8M | 19.8K | 0.67% | — |
| 39 | K KINIKSA PHARMACEUTICALS INTL | $5.6M | 75.7K | 0.66% | — |
| 40 | E ENLIVEN THERAPEUTICS INC | $5.6M | 121.5K | 0.65% | — |
| 41 | S SOLID BIOSCIENCES INC | $5.5M | 760.3K | 0.64% | — |
| 42 | E EVOMMUNE INC | $4.9M | 594.0K | 0.57% | — |
| 43 | S SYNDAX PHARMACEUTICALS INC | $4.7M | 247.4K | 0.54% | — |
| 44 | B BENITEC BIOPHARMA INC | $4.4M | 443.1K | 0.52% | — |
| 45 | R RESEARCH ALLIANCE CORP III | $4.4M | 404.7K | 0.51% | — |
| 46 | ? N/A BLOSSOMHILL THERAPEUTICS INC | $3.8M | 202.1K | 0.44% | — |
| 47 | F FAETH THERAPEUTICS INC | $3.7M | 124.1K | 0.43% | — |
| 48 | A ABEONA THERAPEUTICS INC | $3.6M | 693.4K | 0.43% | — |
| 49 | R RESEARCH ALLIANCE CORP IV | $3.5M | 302.0K | 0.41% | — |
| 50 | A ADLAI NORTYE GROUP LTD | $3.5M | 216.6K | 0.41% | — |